Biodexa Pharmaceuticals (BDRX) Operating Leases (2018 - 2025)
Biodexa Pharmaceuticals (BDRX) posted Operating Leases of $81140.1 for Q4 2025, down 78.71% sequentially from $381200.0 in Q4 2024, and down 78.71% YoY from $381200.0 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Operating Leases (2018 - 2025) Analysis & Trends
Biodexa Pharmaceuticals has reported Operating Leases for 8 years, with the latest figure at $81140.1 in Q4 2025.
- Quarterly Operating Leases fell 78.71% year-over-year to $81140.1 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $81140.1 (down 78.71% YoY) and the FY2025 annual result came in at $80429.1, down 78.9% from the prior year.
- Operating Leases eased to $81140.1 in Q4 2025 per BDRX's latest filing, from $381200.0 in the prior quarter.
- Over five years, Operating Leases peaked at $1.0 million in Q4 2021 and troughed at $81140.1 in Q4 2025.
- A 5-year average of $560543.6 and a median of $575894.5 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2025: Operating Leases soared 928.93% in 2021, then plunged 78.71% in 2025.
- Over 5 years, Operating Leases stood at $1.0 million in 2021, then slipped by 29.12% to $731907.3 in 2022, then dropped by 21.32% to $575894.5 in 2023, then sank by 33.81% to $381200.0 in 2024, then slumped by 78.71% to $81140.1 in 2025.
- According to Business Quant data, Operating Leases over the past three periods registered $81140.1, $381200.0, and $575894.5 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Biodexa Pharmaceuticals | 63,168.17 | -11.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,140.14 |
| Dec 31, 2024 | 381,200.05 |
| Dec 31, 2023 | 575,894.47 |
| Dec 31, 2022 | 731,907.27 |
| Dec 31, 2021 | 1.03 Mn |
| Dec 31, 2020 | 100,354.28 |
| Dec 31, 2019 | 1.17 Mn |
| Dec 31, 2018 | 702,574.91 |